Aspirin reduces the apoptotic effect of etoposide via Akt activation and up-regulation of p21 cip

International Journal of Molecular Medicine

Volumn 28, Issue 4, 2011, Pages 637-643

  Feng, Xiaocheng ^a,b   Lu, Bin ^a   Xu, Yingying ^b   Li, Qin ^a   Zhou, Wenbai ^a   Yang, Zhihong ^a   Yang, Zeng ^a   Zhao, Weiwei ^a   Shen, Zonghou ^b   Hu, Renming ^a  

^a FUDAN UNIVERSITY   (China)

^b FUDAN UNIVERSITY   (China)

Author keywords

Akt; Apoptosis; Aspirin; p21 cip

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; ACETYLSALICYLIC ACID; CASPASE 3; CYCLIN DEPENDENT KINASE INHIBITOR 1; ETOPOSIDE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; PROTEIN P27; PROTEIN P53; SERINE; WORTMANNIN;

APOPTOSIS; ARTICLE; CELL CYCLE ARREST; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; ENZYME ACTIVATION; ENZYME ACTIVITY; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; ASPIRIN; BLOTTING, WESTERN; CYCLIN-DEPENDENT KINASE INHIBITOR P21; ETOPOSIDE; HEP G2 CELLS; HUMANS; PROTO-ONCOGENE PROTEINS C-AKT; REAL-TIME POLYMERASE CHAIN REACTION;

EID: 79960787956     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2011.713     Document Type: Article

References (34)

1. Coleman WB: Mechanisms of human hepatocarcinogenesis. Curr Mol Med 3: 573-588, 2003.
2. Bruix J, Boix L, Sala M and Llovet JM: Focus on hepatocellular carcinoma. Cancer Cell 5: 215-219, 2004. (Pubitemid 38402113)
3. Koga H, Sakisaka S, Ohishi M, Kawaguchi T, Taniguchi E, Sasatomi K, Harada M, Kusaba T, Tanaka M, Kimura R, Nakashima Y, Nakashima O, Kojiro M, Kurohiji T and Sata M: Expression of cyclooxygenase-2 in human hepatocellular carcinoma: relevance to tumor dedifferentiation. Hepatology 29: 688-696, 1999. (Pubitemid 29109581)
4. Bae SH, Jung ES, Park YM, Kim BS, Kim BK, Kim DG and Ryu WS: Expression of cyclooxygenase-2 (COX-2) in hepatocellular carcinoma and growth inhibition of hepatoma cell lines by a COX-2 inhibitor, NS-398. Clin Cancer Res 7: 1410-1418, 2001. (Pubitemid 32717225)
5. Chan AT, Ogino S and Fuchs CS: Aspirin and the risk of colorectal cancer in relation to the expression of COX-2. N Engl J Med 356: 2131-2142, 2007. (Pubitemid 47010839)
6. Van Dyke AL, Cote ML, Prysak G, Claeys GB, Wenzlaff AS and Schwartz AG: Regular adult aspirin use decreases the risk of non-small cell lung cancer among women. Cancer Epidemiol Biomarkers Prev 17: 148-157, 2008 (Pubitemid 351196285)
7. Slattery ML, Curtin K, Baumgartner R, et al: IL6, aspirin, nonsteroidal anti-inflammatory drugs, and breast cancer risk in women living in the southwestern United States. Cancer Epidemiol Biomarkers Prev 16: 747-755, 2007. (Pubitemid 46650577)
8. Lu M, Strohecker A, Chen F, et al: Aspirin sensitizes cancer cells to TRAIL-induced apoptosis by reducing survivin levels. Clin Cancer Res 14: 3168-3176, 2008.
9. Xu XM, Sansores-Garcia L, Chen XM, Matijevic-Aleksic N, Du M and Wu KK: Suppression of inducible cyclooxygenase 2 gene transcription by aspirin and sodium salicylate. Proc Natl Acad Sci USA 96: 5292-5297, 1999. (Pubitemid 29214576)
10. Dikshit P, Chatterjee M, Goswami A, Mishra A and Jana NR: Aspirin induces apoptosis through the inhibition of proteasome function. J Biol Chem 281: 29228-29235, 2006. (Pubitemid 44507066)
11. Pillinger MH, Capodici C, Rosenthal P, et al: Modes of action of aspirin-like drugs: salicylates inhibit Erk activation and integrin-dependent neutrophil adhesion. Proc Natl Acad Sci USA 95: 14540-14545, 1998. (Pubitemid 28549403)
12. Dong Z, Huang C, Brown RE and Ma WY: Inhibition of activator protein 1 activity and neoplastic transformation by aspirin. J Biol Chem 272: 9962-9970, 1997. (Pubitemid 27171667)
13. Yin MJ, Yamamoto Y and Gaynor RB: The anti-inflammatory agents aspirin and salicylate inhibit the activity of I(kappa)B kinase-beta. Nature 396: 77-80, 1998. (Pubitemid 28520452)
14. Kopp E and Ghosh S: Inhibition of NF-kappa B by sodium salicylate and aspirin. Science 265: 956-959, 1994.
15. Gao H, Jin S, Song Y, et al: B23 regulates GADD45a nuclear translocation and contributes to GADD45a-induced cell cycle G2-M arrest. J Biol Chem 280: 10988-10996, 2005. (Pubitemid 40418401)
16. Li Y, Dowbenko D and Lasky LA: AKT/PKB phosphorylation of p21Cip/WAF1 enhances protein stability of p21Cip/WAF1 and promotes cell survival. J Biol Chem 277: 11352-11361, 2002. (Pubitemid 34952901)
17. Grilli M, Pizzi M, Memo M and Spano P: Neuroprotection by aspirin and sodium salicylate through blockade of NF-kappaB activation. Science 274: 1383-1385, 1996. (Pubitemid 26391464)
18. Kutuk O and Basaga H: Aspirin prevents apoptosis and NF-kappaB activation induced by H2O2 in HeLa cells. Free Radic Res 37: 1267-1276, 2003. (Pubitemid 37441710)
19. Hsu CS and Li Y: Aspirin potently inhibits oxidative DNA strand breaks: implications for cancer chemoprevention. Biochem Biophys Res Commun 93: 705-709, 2002.
20. Shi X, Ding M, Dong Z, et al: Antioxidant properties of aspirin: characterization of the ability of aspirin to inhibit silica-induced lipid peroxidation, DNA damage, NF-kappaB activation, and TNF-alpha production. Mol Cell Biochem 199: 93-102, 1999. (Pubitemid 29476147)
21. Chen N, Ma WY and Dong Z: Inhibition of arsenite-induced apoptosis by aspirin. Anticancer Res 21: 3247-3251, 2001. (Pubitemid 34224224)
22. Sairam K, Saravanan KS, Banerjee R and Mohanakumar KP: Non-steroidal anti-inflammatory drug sodium salicylate, but not diclofenac or celecoxib, protects against 1-methyl-4-phenyl pyridinium-induced dopaminergic neurotoxicity in rats. Brain Res 966: 245-252, 2003. (Pubitemid 36255587)
23. Mattie MD and Freedman JH: Protective effects of aspirin and vitamin E (alpha-tocopherol) against copper- and cadmium-induced toxicity. Biochem Biophys Res Commun 285: 921-925, 2001. (Pubitemid 32918024)
24. Cantley LC: The phosphoinositide 3-kinase pathway. Science 296: 1655-1657, 2002.
25. Sussman M: 'AKT'ing lessons for stem cells: regulation of cardiac myocyte and progenitor cell proliferation. Trends Cardiovasc Med 17: 235-240, 2007.
26. di Palma A, Matarese G, Leone V, et al: Aspirin reduces the outcome of anticancer therapy in Meth A-bearing mice through activation of AKT-glycogen synthase kinase signaling. Mol Cancer Ther 5: 1318-1324, 2006. (Pubitemid 43881325)
27. Zhou BP, Liao Y, Xia W, et al: HER-2/neu induces p53 ubiquitination via Akt-mediated MDM2 phosphorylation. Nat Cell Biol 3: 973-982, 2001. (Pubitemid 34428742)
28. Ogawara Y, Kishishita S and Obata T: Akt enhances Mdm2-mediated ubiquitination and degradation of p53. J Biol Chem 277: 21843-21850, 2002. (Pubitemid 34952337)
29. Kim SW, Kim HJ, Chun YJ, et al: Ceramide produces apoptosis through induction of p27(kip1) by protein phosphatase 2A-dependent Akt dephosphorylation in PC-3 prostate cancer cells. J Toxicol Environ Health A 73: 1465-1476, 2010.
30. Cayrol C, Knibiehler M and Ducommun B: p21 binding to PCNA causes G1 and G2 cell cycle arrest in p53-deficient cells. Oncogene 16: 311-320, 1998. (Pubitemid 28052285)
31. Suzuki A, Ito T, Kawano H, Hayashida M, Hayasaki Y, Tsutomi Y, Akahane K, Nakano T, Miura M and Shiraki K: Survivin initiates procaspase 3/p21 complex formation as a result of interaction with Cdk4 to resist Fas-mediated cell death. Oncogene 19: 1346-1353, 2000. (Pubitemid 30160627)
32. Cardone MH, Roy N, Stennicke HR, et al: Regulation of cell death protease caspase-9 by phosphorylation. Science 282: 1318-1321, 1998. (Pubitemid 28524494)
33. Wu W, Lee WL, Wu YY, et al: Expression of constitutively active phosphatidylinositol 3-kinase inhibits activation of caspase 3 and apoptosis of cardiac muscle cells. J Biol Chem 275: 40113-40119, 2000. (Pubitemid 32064637)
34. Koh SH, Kim SH, Kwon H, et al: Epigallocatechin gallate protects nerve growth factor differentiated PC12 cells from oxidative-radical-stress-induced apoptosis through its effect on phosphoinositide 3-kinase/Akt and glycogen synthase kinase-3. Brain Res Mol Brain Res 118: 72-81, 2003. (Pubitemid 37238989)